Leveraging Transfer Superposition Theory for Stable-State Visual Evoked Potential Cross-Subject Frequency Recognition
IEEE Transactions on Biomedical Engineering · 2024
DOI: 10.1109/tbme.2024.3406603 ↗Kurz gefasst
Fachartikel in der Zeitschrift IEEE Transactions on Biomedical Engineering, 2024. Verfasst von Xinjie He und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Evoked Potentials, Visual, Brain-Computer Interfaces, Electroencephalography, Algorithms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: STI 2030-major Projects, National Natural Science Foundation of China, Shanghai Municipal Science and Technology Major Project.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Förderung
- STI 2030-major Projects
- National Natural Science Foundation of China
- Shanghai Municipal Science and Technology Major Project
- Project 211
- National Government Guided Special Funds for Local Science and Technology Development, Shenzhen, China
- Jiangsu Province Science and Technology Plan Special Fund in 2022
Zitieren
APA
He, X., Allison, B. Z., Qin, K., Liang, W., Wang, X., Cichocki, A., & Jin, J. (2024). Leveraging Transfer Superposition Theory for Stable-State Visual Evoked Potential Cross-Subject Frequency Recognition. IEEE Transactions on Biomedical Engineering. https://doi.org/10.1109/tbme.2024.3406603
Vancouver
He X, Allison BZ, Qin K, Liang W, Wang X, Cichocki A, et al. Leveraging Transfer Superposition Theory for Stable-State Visual Evoked Potential Cross-Subject Frequency Recognition. IEEE Transactions on Biomedical Engineering. 2024. doi:10.1109/tbme.2024.3406603
BibTeX
@article{He2024,
author = {He, Xinjie and Allison, Brendan Z and Qin, Ke and Liang, Wei and Wang, Xingyu and Cichocki, Andrzej and Jin, Jing},
title = {Leveraging Transfer Superposition Theory for Stable-State Visual Evoked Potential Cross-Subject Frequency Recognition},
journal = {IEEE Transactions on Biomedical Engineering},
year = {2024},
doi = {10.1109/tbme.2024.3406603}
}
EUVIMED